<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>yourgene health Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestormagazine.co.uk/tag/yourgene-health/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/tag/yourgene-health/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Fri, 07 Jul 2023 21:48:35 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://ukinvestormagazine.co.uk/wp-content/uploads/2025/05/cropped-favicon-96-96-32x32.jpg</url>
	<title>yourgene health Archives - UK Investor Magazine</title>
	<link>https://ukinvestormagazine.co.uk/tag/yourgene-health/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AIM weekly movers: Yourgene Health takeover</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-yourgene-health-takeover/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-yourgene-health-takeover/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 07 Jul 2023 21:48:32 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Glantus Holdings]]></category>
		<category><![CDATA[Harland & Wolff]]></category>
		<category><![CDATA[i(x) Net Zero]]></category>
		<category><![CDATA[Novacyt]]></category>
		<category><![CDATA[quadrise]]></category>
		<category><![CDATA[Restore]]></category>
		<category><![CDATA[UniVision Engineering]]></category>
		<category><![CDATA[yourgene health]]></category>
		<category><![CDATA[Zanaga Iron Ore]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=66236</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="(max-width: 300px) 100vw, 300px" /><p>Yourgene Health (LON: YGEN) is recommending a 0.522p/share cash bid from fellow diagnostics company Novacyt (LON: NCYT). This values Yourgene Health at £16.7m. Last December, Yourgene Health raised £6m at 0.3p/share. Novacyt is spending some of the cash it generated during Covid as it seeks to replace those testing revenues. The Yourgene Health share price [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-yourgene-health-takeover/">AIM weekly movers: Yourgene Health takeover</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-yourgene-health-takeover/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>AIM Movers: Novacyt bid for Yourgene Health and Zanaga Iron Ore funding</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-novacyt-bid-for-yourgene-health-and-zanaga-iron-ore-funding/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-novacyt-bid-for-yourgene-health-and-zanaga-iron-ore-funding/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Mon, 03 Jul 2023 11:22:07 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Alien Metals]]></category>
		<category><![CDATA[Angus Energy]]></category>
		<category><![CDATA[Challenger Energy]]></category>
		<category><![CDATA[Empire Metals]]></category>
		<category><![CDATA[Eurasia Mining]]></category>
		<category><![CDATA[Novacyt]]></category>
		<category><![CDATA[Panthera Resources]]></category>
		<category><![CDATA[Verici Dx]]></category>
		<category><![CDATA[yourgene health]]></category>
		<category><![CDATA[Zanaga Iron Ore]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=66143</guid>

					<description><![CDATA[<img width="300" height="129" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-300x129.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-300x129.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-768x329.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-150x64.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-600x257.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-696x299.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022-979x420.jpg 979w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Novacyt-28042022.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Yourgene Health (LON: YGEN) is recommending a 0.522p/share cash bid from fellow diagnostics company Novacyt (LON: NCYT). This values Yourgene Health at £16.7m. Last December, Yourgene Health raised £6m at 0.3p/share. Novacyt is spending some of the cash it generated during Covid as it seeks to replace those testing revenues. The Yourgene Health share price [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-novacyt-bid-for-yourgene-health-and-zanaga-iron-ore-funding/">AIM Movers: Novacyt bid for Yourgene Health and Zanaga Iron Ore funding</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-novacyt-bid-for-yourgene-health-and-zanaga-iron-ore-funding/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Yourgene sells Taiwan subsidiary and Sound Energy obtains financing deal</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-yourgene-sells-taiwan-subsidiary-and-sound-energy-obtains-financing-deal/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-yourgene-sells-taiwan-subsidiary-and-sound-energy-obtains-financing-deal/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Tue, 13 Jun 2023 11:34:43 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Atlantic Lithium]]></category>
		<category><![CDATA[cap-xx]]></category>
		<category><![CDATA[i(x) Net Zero]]></category>
		<category><![CDATA[IOG]]></category>
		<category><![CDATA[Mirada]]></category>
		<category><![CDATA[Sancus Lending]]></category>
		<category><![CDATA[Sound Energy]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=65675</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Yourgene.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Finance provider Sancus Lending (LON: LEND) shares had been declining prior to this week. The share price has jumped 138.5% to 1.55p today on the back of chief executive Rory Mepham buy one million shares at 0.51p each. Last week, Somerston Fintech and Golf Investments increased their combined stake from 55.5% to 56.6%. Yourgene Health [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-yourgene-sells-taiwan-subsidiary-and-sound-energy-obtains-financing-deal/">AIM movers: Yourgene sells Taiwan subsidiary and Sound Energy obtains financing deal</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-yourgene-sells-taiwan-subsidiary-and-sound-energy-obtains-financing-deal/feed/</wfw:commentRss>
			<slash:comments>3</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Engage XR revenues increase and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-engage-xr-revenues-increase-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-engage-xr-revenues-increase-and-ex-dividends/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 27 Apr 2023 11:16:35 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[CT Automotive]]></category>
		<category><![CDATA[Driver]]></category>
		<category><![CDATA[Engage XR]]></category>
		<category><![CDATA[EnSilica]]></category>
		<category><![CDATA[i(x) Net Zero]]></category>
		<category><![CDATA[Kropz]]></category>
		<category><![CDATA[Synergia Energy]]></category>
		<category><![CDATA[Tower Resources]]></category>
		<category><![CDATA[Vela Technologies]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=64504</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/07/MITIE-Group-26072022.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Extended reality technology provider Engage XR (LON: EXR) says that revenues have increased by two-fifths so far this year thanks to new client wins and renewals. The share price has jumped 18.5% to 3.85p. Having raised £8.8m at 4p a share, the balance sheet is strong with net cash of €10.8m at the end of [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-engage-xr-revenues-increase-and-ex-dividends/">AIM movers: Engage XR revenues increase and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-engage-xr-revenues-increase-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Verditek supply agreement and Circle Property distribution</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-verditek-supply-agreement-and-circle-property-distribution/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-verditek-supply-agreement-and-circle-property-distribution/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 17 Mar 2023 12:34:13 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Circle Property]]></category>
		<category><![CDATA[Neometals]]></category>
		<category><![CDATA[Tekcapital]]></category>
		<category><![CDATA[Verditek]]></category>
		<category><![CDATA[Versarien]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=63624</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-768x513.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-600x401.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-696x465.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022-629x420.jpg 629w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/Kinovo-19082022.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Verditek (LON: VDTK) has signed an exclusive supply agreement to supply solar panels to building and roofing products supplier Lindab Profil AB. They will be sold in the Nordic and eastern European markets. The exclusivity depends on the sale of panels of 850kw in 2023. The share price jumped 25.9% to 0.85p. Graphite technology developer [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-verditek-supply-agreement-and-circle-property-distribution/">AIM movers: Verditek supply agreement and Circle Property distribution</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-verditek-supply-agreement-and-circle-property-distribution/feed/</wfw:commentRss>
			<slash:comments>3</slash:comments>
		
		
			</item>
		<item>
		<title>UK companies that have relationships with Silicon Valley Bank</title>
		<link>https://ukinvestormagazine.co.uk/uk-companies-that-have-relationships-with-silicon-valley-bank/</link>
					<comments>https://ukinvestormagazine.co.uk/uk-companies-that-have-relationships-with-silicon-valley-bank/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Sat, 11 Mar 2023 00:49:19 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Aferian]]></category>
		<category><![CDATA[Diaceutics]]></category>
		<category><![CDATA[Eagle Eye]]></category>
		<category><![CDATA[eEnergy Group]]></category>
		<category><![CDATA[GetBusy]]></category>
		<category><![CDATA[Molten Ventures]]></category>
		<category><![CDATA[puretech]]></category>
		<category><![CDATA[Redcentric]]></category>
		<category><![CDATA[Venture Life]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=63420</guid>

					<description><![CDATA[<img width="300" height="160" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-300x160.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-300x160.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1024x546.jpg 1024w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-768x409.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1536x819.jpg 1536w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-2048x1092.jpg 2048w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-150x80.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-600x320.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-696x371.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1392x742.jpg 1392w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1068x569.jpg 1068w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1920x1023.jpg 1920w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-788x420.jpg 788w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/05/Stagflation-16052022-1576x840.jpg 1576w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Problems at Silicon Valley Bank do not just affect US companies. There are smaller companies on AIM and the Main Market that have facilities provided by the ailing bank. Silicon Valley Bank sold up to $21bn in bonds, taking a loss of nearly $2bn, because of its need for cash. Trading in the bank’s shares [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/uk-companies-that-have-relationships-with-silicon-valley-bank/">UK companies that have relationships with Silicon Valley Bank</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/uk-companies-that-have-relationships-with-silicon-valley-bank/feed/</wfw:commentRss>
			<slash:comments>5</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Allergy Therapeutics accounts delayed and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-allergy-therapeutics-accounts-delayed-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-allergy-therapeutics-accounts-delayed-and-ex-dividends/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 29 Dec 2022 21:44:00 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Allergy Therapeutics]]></category>
		<category><![CDATA[Applied Graphene Materials]]></category>
		<category><![CDATA[Kazera Global Investments]]></category>
		<category><![CDATA[Myanmar International]]></category>
		<category><![CDATA[NetScientific]]></category>
		<category><![CDATA[Pathfinder Minerals]]></category>
		<category><![CDATA[sareum holdings]]></category>
		<category><![CDATA[Tekcapital]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=61616</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Allergy-Therapeutics-1-3-22.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Allergy Therapeutics (LON: AGY) says that its accounts will not be published by the end of 2022, so trading in the shares will be suspended on 3 January. The audit has been delayed, but there is no indication of any material problem. Management is still assessing funding options. The share price slumped 56% to 5p. [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-allergy-therapeutics-accounts-delayed-and-ex-dividends/">AIM movers: Allergy Therapeutics accounts delayed and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-allergy-therapeutics-accounts-delayed-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
		<item>
		<title>AIM weekly movers: Tekmar recovers but no news on strategic investor</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-tekmar-recovers-but-no-news-on-strategic-investor/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-tekmar-recovers-but-no-news-on-strategic-investor/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 23 Dec 2022 22:32:42 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[braveheart investment]]></category>
		<category><![CDATA[City of London Group]]></category>
		<category><![CDATA[Gfinity]]></category>
		<category><![CDATA[Image Scan]]></category>
		<category><![CDATA[Katoro Gold]]></category>
		<category><![CDATA[LBG Media]]></category>
		<category><![CDATA[MS International]]></category>
		<category><![CDATA[Star Phoenix]]></category>
		<category><![CDATA[Tekmar Group]]></category>
		<category><![CDATA[Velocity Composites]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=61570</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Subsea cable protection services provider Tekmar Group (LON: TGP) is recovering some of its recent losses with a 121% improvement in the share price to 16p, although it has still fallen by more than two-thirds this year. Tekmar has won a contract to supply cable protection systems for the third phase of the Dogger Bank [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-tekmar-recovers-but-no-news-on-strategic-investor/">AIM weekly movers: Tekmar recovers but no news on strategic investor</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-tekmar-recovers-but-no-news-on-strategic-investor/feed/</wfw:commentRss>
			<slash:comments>9</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Tekmar contract and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-tekmar-contract-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-tekmar-contract-and-ex-dividends/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 22 Dec 2022 11:39:44 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[600 Group]]></category>
		<category><![CDATA[Deltex Medical Group]]></category>
		<category><![CDATA[Destiny Pharma]]></category>
		<category><![CDATA[i3 Energy]]></category>
		<category><![CDATA[Katoro Gold]]></category>
		<category><![CDATA[Mosman Oil and Gas]]></category>
		<category><![CDATA[Tekmar Group]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=61545</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/12/Tekmar-Group-offshore-energy.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Subsea cable protection services provider Tekmar Group (LON: TGP) has won a contract to supply cable protection systems for the third phase of the Dogger Bank C wind farm in the North Sea. Delivery will start in the third quarter of 2024. Tekmar is already supplying the other phases. There is no news about the [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-tekmar-contract-and-ex-dividends/">AIM movers: Tekmar contract and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-tekmar-contract-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>5</slash:comments>
		
		
			</item>
		<item>
		<title>AIM weekly movers: Agreed Science Group bid for TP Group</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-agreed-science-group-bid-for-tp-group/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-agreed-science-group-bid-for-tp-group/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 04 Nov 2022 23:40:31 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Caspian Sunrise]]></category>
		<category><![CDATA[Firering Strategic Minerals]]></category>
		<category><![CDATA[KEFI Minerals]]></category>
		<category><![CDATA[Longboat Energy]]></category>
		<category><![CDATA[Ncondezi Energy]]></category>
		<category><![CDATA[Osirium Technologies]]></category>
		<category><![CDATA[Parsley Box]]></category>
		<category><![CDATA[Rosslyn Data Technologies]]></category>
		<category><![CDATA[Science Group]]></category>
		<category><![CDATA[TP Group]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=60357</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Science Group (LON: SAG) is buying the shares it does not own in TP Group (LON: TPG) for 2.25p a share in cash. That values TP Group at £17.5m. The share price jumped by 184% to 2.2p, which is the highest the share price has been since June. Science Group already owns 28% of the [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-agreed-science-group-bid-for-tp-group/">AIM weekly movers: Agreed Science Group bid for TP Group</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-agreed-science-group-bid-for-tp-group/feed/</wfw:commentRss>
			<slash:comments>4</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Caspian Sunrise dividend and Enwell Energy court loss</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-caspian-sunrise-dividend-and-enwell-energy-court-loss/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-caspian-sunrise-dividend-and-enwell-energy-court-loss/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 04 Nov 2022 11:48:24 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Caspian Sunrise]]></category>
		<category><![CDATA[Enwell Energy]]></category>
		<category><![CDATA[Longboat Energy]]></category>
		<category><![CDATA[Thor Mining]]></category>
		<category><![CDATA[TLOU Energy]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=60332</guid>

					<description><![CDATA[<img width="300" height="225" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-300x225.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-300x225.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-768x576.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-560x420.jpg 560w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-80x60.jpg 80w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-100x75.jpg 100w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-180x135.jpg 180w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-238x178.jpg 238w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-640x480.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field-681x511.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/08/Egdon-Resources-Wressle-Oil-Field.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Oil and gas producer Caspian Sunrise (LON: CASP) is paying its first dividend of 0.0444p a share and promises monthly payouts. The dividend will be based on 35%-40% of free cash flows or a minimum of £1m. Production is currently 2,400 barrels/day. The oil is being sold locally, but an international trading subsidiary is being [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-caspian-sunrise-dividend-and-enwell-energy-court-loss/">AIM movers: Caspian Sunrise dividend and Enwell Energy court loss</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-caspian-sunrise-dividend-and-enwell-energy-court-loss/feed/</wfw:commentRss>
			<slash:comments>6</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Extensive copper anomaly for Empire Metals and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-extensive-copper-anomaly-for-empire-metals-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-extensive-copper-anomaly-for-empire-metals-and-ex-dividends/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 03 Nov 2022 12:24:10 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Empire Metals]]></category>
		<category><![CDATA[Future Metals]]></category>
		<category><![CDATA[Gattaca]]></category>
		<category><![CDATA[Insig AI]]></category>
		<category><![CDATA[Libertine Holdings]]></category>
		<category><![CDATA[Longboat Energy]]></category>
		<category><![CDATA[PetroTal]]></category>
		<category><![CDATA[Xpediator]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=60306</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Empire-Metals-24062022.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Empire Metals (LON: EEE) says the mapping of the Pitfield copper project show extensive copper, silver and other base metals anomalies of a 40km strike length. Exploration field work will start by the first quarter of 2023. The share price is 26% higher at 1.575p. There is better third quarter trading news from freight services [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-extensive-copper-anomaly-for-empire-metals-and-ex-dividends/">AIM movers: Extensive copper anomaly for Empire Metals and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-extensive-copper-anomaly-for-empire-metals-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>7</slash:comments>
		
		
			</item>
		<item>
		<title>Yourgene Health set to reap benefits of investment</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-health-set-to-reap-benefits-of-investment/</link>
					<comments>https://ukinvestormagazine.co.uk/yourgene-health-set-to-reap-benefits-of-investment/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Wed, 11 Aug 2021 20:43:10 +0000</pubDate>
				<category><![CDATA[Premium]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[UK Investor Vantage]]></category>
		<category><![CDATA[LON:YGEN]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=41224</guid>

					<description><![CDATA[<img width="300" height="187" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-300x187.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-300x187.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-768x478.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-674x420.jpg 674w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-640x399.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics-681x424.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/09/Curetis-molecular-diagnostics.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Investments made by Yourgene Health (LON: YGEN) will start to pay off this year, which will include a full 12-month contribution from the US business acquired last year. The first quarter of the current financial year has started strongly, and Yourgene Health is on course to move into profit this year. Yourgene Health is an [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/yourgene-health-set-to-reap-benefits-of-investment/">Yourgene Health set to reap benefits of investment</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/yourgene-health-set-to-reap-benefits-of-investment/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Yourgene Health shares plunge as lockdown impacts H1 results</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-health-shares-plunge/</link>
					<comments>https://ukinvestormagazine.co.uk/yourgene-health-shares-plunge/#respond</comments>
		
		<dc:creator><![CDATA[Safiya Bashir]]></dc:creator>
		<pubDate>Mon, 26 Oct 2020 08:39:38 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[corona]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Results]]></category>
		<category><![CDATA[trading update]]></category>
		<category><![CDATA[yourgene health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32049</guid>

					<description><![CDATA[<img width="300" height="149" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-300x149.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-300x149.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-768x381.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-847x420.jpg 847w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-640x317.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software-681x338.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/EMIS-Group-healthcare-software.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Yourgene Health Plc shares (LON: YGEN) plunged 11.54% on Monday&#8217;s opening bell after the group shared results for the half-year ended 30 September 2020. Revenues for the half-year were up 5% to £8.2m with &#8220;strong European revenues offsetting the headwinds from COVID-19 on international sales.&#8221; Impacts from the pandemic were offset by the strong UK [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/yourgene-health-shares-plunge/">Yourgene Health shares plunge as lockdown impacts H1 results</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/yourgene-health-shares-plunge/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
